These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 577299

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Quantitative description of loss of clinical benefit following withdrawal of levodopa-carbidopa and bromocriptine in early Parkinson's disease.
    Hauser RA, Holford NH.
    Mov Disord; 2002 Sep; 17(5):961-8. PubMed ID: 12360545
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Low CSF GABA in Parkinsonian patients who respond poorly to therapy or suffer from the "on-off" phenomenon.
    Teychenné PF, Ziegler MG, Lake CR, Enna SJ.
    Ann Neurol; 1982 Jan; 11(1):76-9. PubMed ID: 6120678
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Dopamine and serotonin turnover rate in the retina of rabbit, rat, goldfish, and Eugerres plumieri: light effects in goldfish and rat.
    Lima L, Urbina M.
    J Neurosci Res; 1994 Dec 01; 39(5):595-603. PubMed ID: 7534358
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Serotonergic activation after 2-week intrastriatal infusion of L-dopa and slow recovery of circling in rats with unilateral nigral lesions.
    Kääriäinen TM, García-Horsman JA, Piltonen M, Huotari M, Männistö PT.
    Basic Clin Pharmacol Toxicol; 2008 Mar 01; 102(3):300-7. PubMed ID: 17973898
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Comparison of bromocriptine and levodopa as first line treatment of Parkinson's disease: results of a 3-year prospective randomized study].
    Montastruc JL, Rascol O, Rascol A.
    Rev Neurol (Paris); 1990 Mar 01; 146(2):144-7. PubMed ID: 2181588
    [Abstract] [Full Text] [Related]

  • 35. [L-dopa treatment in parkinsonism. Biochemical basis (author's transl)].
    Bieniowa A, Kolasa M, Reichowa J.
    Przegl Lek; 1976 Mar 01; 33(4):463-7. PubMed ID: 1273343
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa.
    Parkes JD, Debono AG, Marsden CD.
    J Neurol Neurosurg Psychiatry; 1976 Nov 01; 39(11):1101-8. PubMed ID: 1036999
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.